With the undeniable excitement in the BCMA field over the past few months, the BCMA Targeted Therapies Summit returns to the space to equip you with the knowledge and connections to revolutionize your BCMA-centered pipeline.
Pick the brains of 90+ academic and industry pioneers at the first physical edition of the only meeting dedicated to supercharging transformative next generation BCMA-targeted therapies into the clinic, navigating the complex landscape and optimizing clinical strategy to revolutionize treatment of multiple myeloma and beyond.
Hear from experts including:
- Johnson & Johnson
- 2seventy bio
- Bristol Myers Squibb
- Legend Biotech
This post was originally published on Source Link